“…
The chance observation, made during clinical work on the tuberculostatic activity of iproniazid, that the compound had a "mood elevating" effect led to intensive experimental studies, expecially by Zeller and his group, recently reviewed by ZELLER (1960). They found iproniazid to be a potent inhibitor of mono-amine oxidase (MAO).
…”